- Home
- Publications
- Publication Search
- Publication Details
Title
GLS2 is protumorigenic in breast cancers
Authors
Keywords
-
Journal
ONCOGENE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-20
DOI
10.1038/s41388-019-1007-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- As Extracellular Glutamine Levels Decline, Asparagine Becomes an Essential Amino Acid
- (2018) Natalya N. Pavlova et al. Cell Metabolism
- A tale of two glutaminases: homologous enzymes with distinct roles in tumorigenesis
- (2017) William P Katt et al. Future Medicinal Chemistry
- Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition
- (2017) Michael Lampa et al. PLoS One
- Metabolic Differences in Glutamine Utilization Lead to Metabolic Vulnerabilities in Prostate Cancer
- (2017) Niki Marie Zacharias et al. Scientific Reports
- Glutaminase 2 stabilizes Dicer to repress Snail and metastasis in hepatocellular carcinoma cells
- (2016) Tsang-Chih Kuo et al. CANCER LETTERS
- Expression of epithelial-mesenchymal transition–related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome
- (2015) Min Hye Jang et al. HUMAN PATHOLOGY
- Opposing roles of glutaminase isoforms in determining glioblastoma cell phenotype
- (2015) Monika Szeliga et al. NEUROCHEMISTRY INTERNATIONAL
- Asparagine Depletion Potentiates the Cytotoxic Effect of Chemotherapy against Brain Tumors
- (2014) Eduard H. Panosyan et al. MOLECULAR CANCER RESEARCH
- Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer
- (2014) M. I. Gross et al. MOLECULAR CANCER THERAPEUTICS
- A Distinct Reactive Oxygen Species Profile Confers Chemoresistance in Glioma-Propagating Cells and Associates with Patient Survival Outcome
- (2013) Lynnette Wei-Hsien Koh et al. ANTIOXIDANTS & REDOX SIGNALING
- Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target
- (2013) Luika A. Timmerman et al. CANCER CELL
- Assessment of gene expression of intracellular calcium channels, pumps and exchangers with epidermal growth factor-induced epithelial-mesenchymal transition in a breast cancer cell line
- (2013) Felicity M Davis et al. Cancer Cell International
- In Vivo HIF-Mediated Reductive Carboxylation Is Regulated by Citrate Levels and Sensitizes VHL-Deficient Cells to Glutamine Deprivation
- (2013) Paulo A. Gameiro et al. Cell Metabolism
- Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
- (2013) Jaekyoung Son et al. NATURE
- Integrative Molecular Profiling Reveals Asparagine Synthetase Is a Target in Castration-Resistant Prostate Cancer
- (2012) Kanishka Sircar et al. AMERICAN JOURNAL OF PATHOLOGY
- Analysis of glutamine dependency in non-small cell lung cancer
- (2012) A. Pieter J. van den Heuvel et al. CANCER BIOLOGY & THERAPY
- The Metabolic Profile of Tumors Depends on Both the Responsible Genetic Lesion and Tissue Type
- (2012) Mariia O. Yuneva et al. Cell Metabolism
- Mammalian Glutaminase Gls2 Gene Encodes Two Functional Alternative Transcripts by a Surrogate Promoter Usage Mechanism
- (2012) Mercedes Martín-Rufián et al. PLoS One
- Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC
- (2012) W. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mitochondrial localization and structure-based phosphate activation mechanism of Glutaminase C with implications for cancer metabolism
- (2012) A. Cassago et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- miR-22 represses cancer progression by inducing cellular senescence
- (2011) Dan Xu et al. JOURNAL OF CELL BIOLOGY
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Glutamine Synthetase Is a Genetic Determinant of Cell Type–Specific Glutamine Independence in Breast Epithelia
- (2011) Hsiu-Ni Kung et al. PLoS Genetics
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation
- (2010) Jian-Bin Wang et al. CANCER CELL
- Inhibition of Glutaminase Preferentially Slows Growth of Glioma Cells with Mutant IDH1
- (2010) M. J. Seltzer et al. CANCER RESEARCH
- The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism
- (2010) K. E. Wellen et al. GENES & DEVELOPMENT
- ERK2 but Not ERK1 Induces Epithelial-to-Mesenchymal Transformation via DEF Motif-Dependent Signaling Events
- (2010) Sejeong Shin et al. MOLECULAR CELL
- Targeting EGFR Induced Oxidative Stress by PARP1 Inhibition in Glioblastoma Therapy
- (2010) Masayuki Nitta et al. PLoS One
- Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species
- (2010) S. Suzuki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function
- (2010) W. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
- (2009) Ping Gao et al. NATURE
- Asparagine synthetase is a predictive biomarker of l-asparaginase activity in ovarian cancer cell lines
- (2008) Philip L. Lorenzi et al. MOLECULAR CANCER THERAPEUTICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started